(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
@ $9.40
Utstedt: 14 feb 2024 @ 19:07
Avkastning: -25.11%
Forrige signal: feb 14 - 17:58
Forrige signal:
Avkastning: 1.68 %
Live Chart Being Loaded With Signals
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications...
Stats | |
---|---|
Dagens volum | 1.14M |
Gjennomsnittsvolum | 1.24M |
Markedsverdi | 923.50M |
EPS | $0 ( 2024-05-02 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.52 |
ATR14 | $0.0110 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-29 | Rahmer Peter | Sell | 1 345 | Common Stock |
2024-04-29 | Adams Brian | Sell | 1 623 | Common Stock |
2024-04-29 | Catinazzo Thomas | Sell | 1 695 | Common Stock |
2024-04-29 | Bergstrom Donald A | Sell | 2 686 | Common Stock |
2024-03-27 | Catinazzo Thomas | Sell | 348 | Common Stock |
INSIDER POWER |
---|
88.11 |
Last 99 transactions |
Buy: 4 152 455 | Sell: 364 261 |
Volum Korrelasjon
Relay Therapeutics, Inc. Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
TXG | 0.941 |
NEOG | 0.926 |
GLPG | 0.926 |
AMPH | 0.925 |
MAXN | 0.923 |
DCFC | 0.92 |
BGFV | 0.917 |
BIRD | 0.914 |
NVTS | 0.913 |
PRTS | 0.911 |
10 Mest negative korrelasjoner | |
---|---|
GRCL | -0.916 |
MSAC | -0.902 |
IVCB | -0.899 |
FTGC | -0.899 |
GGAL | -0.898 |
TZPS | -0.897 |
TRMR | -0.891 |
GHRS | -0.889 |
RETA | -0.889 |
AEYE | -0.887 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Relay Therapeutics, Inc. Korrelasjon - Valuta/Råvare
Relay Therapeutics, Inc. Økonomi
Annual | 2023 |
Omsetning: | $25.55M |
Bruttogevinst: | $20.28M (79.37 %) |
EPS: | $-2.79 |
FY | 2023 |
Omsetning: | $25.55M |
Bruttogevinst: | $20.28M (79.37 %) |
EPS: | $-2.79 |
FY | 2022 |
Omsetning: | $1.38M |
Bruttogevinst: | $-2.75M (-199.06 %) |
EPS: | $-2.27 |
FY | 2021 |
Omsetning: | $3.03M |
Bruttogevinst: | $3.03M (100.00 %) |
EPS: | $-3.93 |
Financial Reports:
No articles found.
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for patients with advanced or metastatic FGFR2-altered solid tumors; RLY-2608, a lead mutant-PI3Ka inhibitor program that targets phosphoinostide 3 kinase alpha; and RLY-1971, an oral small molecule inhibitor of protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2 that is in Phase 1 trial in patients with advanced solid tumors. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; and Genentech, Inc. for the development and commercialization of RLY-1971. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.